Latest signal
last curated pass Oct 8, 2026 · 8 public entries · source-aware summaries from 6 legacy curated cards plus llm-wiki tweets
Recent curated signals
Media “The shame arbitrage press used against me for years is now eliminated”: the Axios interview lands, a second status signal amplifies a 500-year-lifespan musing, and a childhood-decline stats post draws on verified CDC/SEARCH figures October 8 produced a three-post cluster spanning media reception and the status arc. The anchor: “The shame arbitrage press used against me for years is now eliminated. In this interview, I flexed my: night time erection duration, fertility health, biological age, and that I’m trying to dunk at 49. And, Axios rolled with it. Unthinkable 2 yrs ago. Would’ve been skewered for this weirdness. You can just do things.” The interview is real and the quoted claims verify against Axios’s own October 8 coverage of “The Axios Show” episode: “What creates status and power and prestige is going to be different. And as crazy as it sounds, it may be your nighttime erections... It may be your ability to dunk a basketball at age 49” — a direct restatement of the October 7 status-games thesis now placed in mainstream-outlet framing, alongside the tracked dunk side quest, 4.2 billion collected data points, and the $2M+/yr spend. Two companion posts extended the arc: “another high status signal” quote-posted Mike Solana (Founders Fund CMO and Pirate Wires founder) musing “sort of landing on: if we don’t get the AI apocalypse the average human lifespan maybe jumps to like 500 years or something?” (999 likes) — another high-reach figure normalizing radical life extension, the exact adoption mechanism Johnson theorized on October 7; and the evening stats post: “They’re in biological decline before their parents” with childhood-obesity figures (1988–2023 doubling from 10% to 21.1%, severe obesity nearly tripling 2.6%→7%, type 2 diabetes rising 5.3%/yr 2002–2018). All three figures verify: CDC/NCHS Health E-Stat tables report child/adolescent obesity 10.0% (1988–1994) → 21.1% (Aug 2021–Aug 2023) with severe obesity 2.6% → 7.0%, and the SEARCH for Diabetes in Youth study (Lancet Diabetes & Endocrinology, 2023) reports youth-onset type 2 diabetes incidence rising 5.31%/yr (95% CI 4.46–6.17) from 2002–2018. The boundaries: the obesity “doubling” is prevalence, not incidence, and the series compares survey waves, not continuous measurement; “biological decline before their parents” is Johnson’s framing of correlation, not a demonstrated cross-generational comparison; the Solana quote is a speculative musing, not a forecast or expert consensus; “shame arbitrage is eliminated” is a perception claim about press treatment, not evidence of social change; and nothing here is medical advice. The dashboard records an attributed media/status cluster with verified statistics and interview context—not a demonstrated status shift, a life-expectancy forecast, a pediatric-health directive, or medical advice. 7 sourcesMedia reception / status games / child metabolic health Ideology Health as the premium status symbol: Johnson amplifies CZ’s “compete on health, not lambos” post and sets a 75,000-person adoption threshold October 7 produced the ideology’s first full status-games cluster. Johnson quote-posted Binance founder CZ’s viral shirtless photo (“Not my usual style to post half naked photos, but what the hell... Also 49, no AI, no photoshop, pure human labor... I encourage people to compete on health, not wealth rankings or lambos,” 38.7k likes) and read it as “a high status member of society signaling that health is the premium status symbol,” adding his own quantified gate: “The critical threshold for mass adoption will happen at around 75,000 similarly powerful people saying the same thing.” Two follow-ups built the thesis — “Sitting, typing, scrolling and martyring oneself for money are about to lose status. The new status games will reward what can’t be automated or faked: a body and mind in peak ability” (repeating the manifesto’s automation-removes-discipline framing) and the premise post: “Humans are status seeking monkeys. We can’t help ourselves. We are wired neurologically, biochemically and culturally to sacrifice whatever necessary to achieve relative rank. This is why societal role models are so important: they create the status games society plays.” The checkable parts verify in direction: CZ’s “49” is accurate (born September 10, 1977), and the status-motive premise matches the evolutionary status literature (Cheng, Tracy, Foulsham, Kingstone and Henrich’s dominance–prestige account, JPSP 104(1), 2013). The 75,000 threshold has no cited basis, and the nearest published result measures a different unit: Centola, Becker, Brackbill and Baronchelli’s 2018 Science coordination experiments (10.1126/science.aas8827) found committed minorities tipping group conventions at roughly 25% of small interacting populations — a fraction of a bounded group, not an absolute count of global elites — and the paper itself states the value “is not expected to be a universal value.” The image’s “no AI, no photoshop” claim is unverifiable, the “lose status” post is a prediction, and nothing in the cluster is evidence that status games are actually shifting. The dashboard records an attributed ideology cluster with verified biographical and literature context—not a demonstrated social trend, a validated adoption threshold, or medical advice. 6 sourcesDon’t Die ideology / status games Ideology “Am I a madman or messiah?”: the Don’t Die origin story — biographies, Schopenhauer’s marksman, and “Don’t Die is the Zero” Johnson closed October 6 with the movement’s origin story: “Am I a madman or messiah? … For 30 years I’ve worked to create something of enduring value for the human race.” The essay runs from a biography-driven epistemology (autobiographies “preserve the high resolution nuance that broad histories discard”) through a quantitative-sounding compression thesis — “Every generation’s existence is compressed by around 90%,” so three generations leave “one in a thousand figures, ideas, or works” in cultural memory — to the people he admired: those who found their era’s “Zero,” the central defining issue others couldn’t see, footed with Schopenhauer’s “Talent hits a target no one else can hit. Genius hits a target no one else can see.” The quotation verifies: the marksman passage is genuine Schopenhauer (World as Will and Representation, Vol. II, ch. 31, “On Genius”), with the one-line form the standard condensed rendering and Johnson’s parenthetical first-principle/zeroth-principle glosses his own additions. The trajectory that follows — wealth by 30 as the enabling goal, “At age 34, I sold Braintree Venmo in 2013 for $800M, making $300M of that,” a 2500 thought experiment whose answer is gratitude that 21st-century humans “gave birth to superintelligence and figured out they’d no longer die” — lands on “Don’t Die is the Zero,” a values shift from killing for “power, wealth and status” to “valuing existence itself above all other rewards,” an era commencing in 2030 (restated verbatim in a same-day standalone post), and the self-description “We are performance artists. We are memetic representations.” The boundaries: the $800M exit matches the tracked Braintree record, but “age 34” does not reconcile with the tracked August 1977 birth date and the 2013 close (he would have been 36) and is recorded as a discrepancy; the $300M personal take and the 90%/99.9% compression figures are uncited; the 2030 commencement and GLP-1/body-positivity analogy repeat his September 17 framing; and nothing in the post is evidence about mortality. The dashboard records an attributed ideology-and-autobiography manifesto with verified quotation provenance—not evidence about mortality, a social prediction, or medical advice. 3 sourcesDon’t Die ideology / autobiography Research claim Correcting the creatine “muscle without exercise” hype: Johnson’s water-retention critique of the Texas A&M RCT — design facts verify, the mechanism is asserted Johnson quote-posted a 17.6k-like thread celebrating a new creatine trial — “People who never trained took 10g of creatine a day and gained more lean tissue (2.43 lbs) than people who were lifting 3x a week with no creatine (0.31 lbs)” — and argued the opposite: “Creatine didn’t build muscle or burn fat in this study. It was water retention. Exercise wasn’t randomized. Participants chose whether to train. DEXA scans count water as ‘lean mass’.” The trial is real and the checkable parts of the critique verify: Chun, Kreider et al. (Journal of the International Society of Sports Nutrition, 2026, 10.1080/15502783.2026.2716273; ISRCTN83081058) enrolled 73 sedentary adults aged 45–65 (64 completers) who chose their exercise arm and were then randomized double-blind to 10 g/day creatine monohydrate or maltodextrin placebo for 12 weeks with DXA body composition — the no-exercise creatine arm gained +1.1 kg lean tissue versus +0.14 kg for exercise-placebo, exactly the thread’s 2.43-lb/0.31-lb pair — and DEXA genuinely cannot separate muscle protein from water, a limitation the trial could not rule out because it reports no body-water measurement. The boundaries run both ways: “It was water retention” is a mechanism asserted as a finding — the same no-exercise creatine arm also increased 1RM strength, which intracellular hydration alone does not obviously explain — the no-exercise arms were small (about 13 completers each; lean-mass CI 0.2–2.0 kg), the trial’s larger body-fat-percentage reduction belonged to the exercise-plus-diet arm where real fat loss was the design, and the senior author’s creatine-industry ties (AlzChem supplied the creatine) are disclosed rather than hidden. The dashboard records an attributed evidence critique with verified trial-design facts—not a determination of what the lean-mass gain consisted of, a creatine recommendation or warning, or medical advice. 4 sourcesSupplement evidence / body-composition measurement N=1 test The altitude arc gets an unplanned coda: a self-injuring night terror attributed to five days at 7,000 ft plus missed bedtimes The October 4 “order has been restored” epilogue acquired a footnote two nights later: Johnson reported a night terror — “throwing myself off the bed and bloodying up my back, sides and arms” after dreaming of jumping off a runaway train — a recurrence of a past problem he says once put him in the hospital. His mechanism section is accurate against sleep medicine: night terrors are non-REM disorders of arousal arising from deep slow-wave (stage N3) sleep in the first third of the night — his “1-3 hours after sleep onset” matches the documented one-to-three-hour window — REM’s muscle atonia is why ordinary nightmares are not acted out, and sleep deprivation is a documented precipitant. His causal attribution (five days at 7,000 ft while missing bedtimes for consecutive social events) is consistent with the September 29–30 wearable-dip/rebound arc and with acclimatization timelines of several weeks. The boundaries: this is a self-diagnosed, unmonitored account — no polysomnography, no clinician named, and the “research” he did is uncited — and adult night terrors with self-injury are a presentation sleep medicine associates with underlying conditions worth clinical evaluation. The dashboard records an attributed N=1 event narrative with verified mechanism context—not evidence that altitude travel causes night terrors, a sleep-safety guideline, or medical advice. 3 sourcesSleep / parasomnia / altitude recovery Female health Quote-posting Tolo’s female-health thread: the Ambien claim that verifies nearly verbatim against the FDA label Johnson quote-posted the zolpidem fact from Kate Tolo’s five-fact female-health thread: “Studies found that women had around 45% higher blood concentrations of ambien (zolpidem) than men after the same dose. Women also cleared the drug from the bloodstream more slowly.” This one is about as checkable as feed claims get: the FDA Ambien label’s “Gender Difference in Pharmacokinetics” section states that Cmax and AUC were “approximately 45% higher at the same dose in female subjects compared with male subjects” because “women clear zolpidem tartrate from the body at a lower rate than men,” and the FDA’s January 2013 safety communication halved the recommended bedtime dose for women (10 mg to 5 mg immediate-release; 12.5 mg to 6.25 mg extended-release) on next-morning-impairment data. The quoted claim is, in effect, the label. The boundaries: the post is a quote-post amplification rather than new analysis, it names no source itself (the figures belong to the FDA documents), and zolpidem is a Schedule IV prescription hypnotic whose dosing is a clinician decision. The dashboard records an attributed female-health claim with verified regulatory provenance—not a dosing directive, a medication change without a prescriber, or medical advice. 4 sourcesSex-specific pharmacokinetics / female-health claims Research claim “The male body by age 50”: five decline figures and a weekly counter-protocol, three of five verifiable Johnson’s highest-engagement post in weeks (5.6k likes) lists five decline figures — testosterone down 30%, arterial stiffness up 30%, bone density down 10%, muscle mass down 10%, prostate enlargement in 50% of men — against a weekly counter-protocol: 4 hr heavy lifting, 3 hr zone 2, 45 min HIIT, 2 hr sauna, 8 hr/night sleep. Three of the five figures verify against named literatures: the testosterone figure tracks the Massachusetts Male Aging Study’s longitudinal total-testosterone decline of about 1.6%/yr (compounding to roughly −28% from peak by 50, with free/bioavailable testosterone falling faster at 2–3%/yr; the Baltimore Longitudinal Study found the same direction); the muscle figure matches cross-sectional medians of about 4.7% of peak mass per decade in men (≈10% from 30 to 50); and the prostate figure matches Berry et al.’s classic autopsy series exactly — 50% of men show pathological benign prostatic hyperplasia at ages 51–60. The arterial-stiffness and bone-density percentages name no source and are recorded as attributed values, and the prescription is Johnson’s own weekly stack, not a clinical recommendation — no volume in it is an individually optimized dose, and the post cites no trial of the combined stack. The dashboard records an attributed claims-plus-protocol post with verified context for three figures—not a diagnosis, a male-aging checklist, or medical advice. 5 sourcesMale aging / exercise and sauna prescription Algorithmic health The readout arrives: Lütke’s race physiology reviewed — 171 bpm peak, 4.6% body mass lost, 41 breaths/min — but still no blood panel The October 2 “reviewing Tobi’s performance via biomarkers” announcement produced its narrative readout. Johnson reconstructed Lütke’s 2.5-hour Petit Le Mans stint physiologically — heart rate peaking at 171 bpm and already at 136 bpm thirty minutes before the race, qualifying laps faster as heart rate rose, 4.6% of body mass lost to sweat, breathing averaging 41 breaths/min on flying laps (93 liters/min, peaking at 59) — closing with performance context (fastest race lap on lap 88 at 1:15.359, over two hours in; +2.60% off class best against world-class professionals; 150 drivers) and a flow-state neuroscience frame: downregulated prefrontal self-monitoring, norepinephrine-driven time dilation, and the same one-brain-region-vs-fifteen compression the October 3 post used. The one checkable side-claim verifies with a caveat: “at 2% dehydration your reaction time measurably decreases” matches the direction of the Wittbrodt & Millard-Stafford meta-analysis (Med Sci Sports Exerc, 2018: cognitive impairment greater beyond 2% body-mass loss), but that analysis found reaction-time-specific effects nonsignificant (ES −0.10) — attention, executive function, and motor coordination are the impaired domains. The structural boundary is unchanged: the announced “deep molecular profiling” blood draws still have no panel, method, or result — this readout is wearable-and-telemetry narrative, not the molecular data, and whether the pre/post blood comparison yields anything remains unpublished. The dashboard records an attributed readout narrative with verified hydration-literature context—not evidence that biomarker review improves driving performance, a hydration strategy, or medical advice. 4 sourcesMethod export / motorsport physiology
// Reference paths
Move from feed to dossiers
Each route keeps source trails and medical caution visible. Protocol Health
Habits, Longterm, and Don’ts for measurement loops, sleep consistency, oral care, exercise, and experimental-intervention caution.
Protocol LongevityHabits, Longterm, and Don’ts for biomarkers, healthspan basics, critiques, and low-confidence immortality claims.
Protocol NutritionHabits, Longterm, and Don’ts for plant-led meals, Blueprint products, microplastics claims, and metabolic-drug caveats.
Protocol SleepHabits, Longterm, and Don’ts for bedtime discipline, front-loading examples, and metric caution from tweet-backed sources.
Reference Concepts39 source-aware glossary entries, including concepts without dedicated wiki pages yet.
entity BlueprintBlueprint is bryan-johnson's longevity protocol, product company, and public measurement system. It began as Project Blueprint, an N=1 effort to measure Johnson's organs and biological aging, and later became a consumer
concept Blueprint ProtocolThe Blueprint Protocol is bryan-johnson's closed-loop health system: measure body state, consult scientific evidence, implement interventions, measure again, and update. Johnson treats the body as a system whose organs a
concept Don't DieDon't Die is bryan-johnson's community slogan, longevity philosophy, and civilizational frame. The official Don't Die page describes a community “united in defeating all causes of human and planetary death and building a
concept Biomarker-driven longevity protocolsA biomarker-driven longevity protocol is a health system that treats the body as a measurable control system: collect biomarkers, choose interventions, re-measure, and iterate. project-blueprint is the most visible curre
Signal MetricsInspect source velocity by range, content type, and fallback API state.